Arrowhead Pharmaceuticals, Inc. (ARWR)
NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
Show:
Annual
Cash Flow
All numbers in thousandsBreakdown
ttm
2023-09-30
2022-09-30
2021-09-30
2020-09-30
2019-09-30
Cash flows from operating activities
Net Income
-470,789
-205,275
-176,063
-140,848
-84,553
-
Depreciation & amortization
15,923
12,493
10,421
8,267
5,942
-
Stock based compensation
75,572
78,130
120,893
76,673
43,383
-
Change in working capital
107,184
-51,547
-98,293
228,662
-61,078
-
Accounts receivable
69,434
1,410
8,845
-9,409
-184
-
Accounts Payable
17,908
32,998
-6,589
2,628
-821
-
Other working capital
-470,163
-330,627
-188,908
147,745
-107,753
-
Other non-cash items
23,032
18,326
2,910
266
525
-
Net cash provided by operating activites
-256,920
-153,890
-136,131
171,312
-95,801
-
Cash flows from investing activities
Investments in property, plant and equipment
-213,243
-176,737
-52,777
-23,567
-11,952
-
Purchases of investments
-20,995
-246,141
-223,391
-240,703
-278,964
-
Sales/Maturities of investments
393,344
326,723
270,751
122,592
50,138
-
Net cash used for investing activites
-183,494
-96,155
-5,417
-141,678
-240,778
-
Cash flows from financing activities
Debt repayment
-0.001
-
-
0
0
-2,415
Common stock issued
-
-
0
0
250,479
60,522
Other financing activites
-
250,000
60,000
-
-
-
Net cash used privided by (used for) financing activities
433,001
253,053
65,186
11,305
257,948
-
Net change in cash
-7,413
3,008
-76,362
40,939
-78,631
-
Cash at beginning of period
134,959
108,005
184,434
143,583
221,804
-
Cash at end of period
127,546
110,891
108,005
184,434
143,583
-
Free Cash Flow
Operating Cash Flow
-256,920
-153,890
-136,131
171,312
-95,801
-
Capital Expenditure
-213,243
-176,737
-52,777
-23,567
-11,952
-
Free Cash Flow
-470,163
-330,627
-188,908
147,745
-107,753
-
© 2024 Yahoo. All rights reserved.